Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) (SDALS-001)

This study has been completed.
Sponsor:
Collaborators:
ALS Therapy Alliance
State University of New York - Upstate Medical University
Information provided by (Responsible Party):
Nazem Atassi, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01257581
First received: December 8, 2010
Last updated: March 12, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)